The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting risk of chemotherapy-induced side effects in patients with colon cancer with single-nucleotide polymorphism (SNP) Bayesian networks (BNs).
Stephen T. Sonis
Consultant or Advisory Role - Inform Genomics
Stock Ownership - Inform Genomics
Research Funding - Inform Genomics
Lee Steven Schwartzberg
Research Funding - Inform Genomics
Mark S. Walker
Research Funding - Inform Genomics
Susan M Weidner
Employment or Leadership Position - Inform Genomics (U)
Stock Ownership - Inform Genomics
Gil Alterovitz
Consultant or Advisory Role - Inform Genomics
Stock Ownership - Inform Genomics
Research Funding - Inform Genomics